Avalo
Avalo Therapeutics
Quick answer
Avalo is a pharma company (AVTX) headquartered in WAYNE, PA, USA with 16 tracked pipeline programs.
Pipeline (16)
NFC-1
Attention Deficit Disorder With Hyperactivity
1 trials projectAEVI-001
Attention Deficit Hyperactivity Disorder
2 trials projectAVTX-002
Non-Eosinophilic Asthma
1 trials projectAVTX-009 Regimen 1
Hidradenitis Suppurativa
1 trials projectCERC-002
COVID-19 Pneumonia
1 trials projectCERC-301
Major Depressive Disorder
2 trials projectFP01
Chronic Refractory Cough
1 trials projectFP01
Acute Cough
1 trials projectMDGN201 TARGTEPO
Anemia of End Stage Renal Disease
1 trials projectAEVI-007
Multiple Myeloma
1 trials projectCERC-006
Lymphatic Malformation
1 trials projectFP01
Healthy
1 trials projectMDGN-002
Crohn Disease
1 trials projectNFC-1
Attention-deficit Hyperactivity Disorder (ADHD)
1 trials projectNFC-1
22q11.2 Deletion Syndrome
1 trials projectNFC-1 100 mg
Attention Deficit Disorder With Hyperactivity
1 trialsPatents (8)
US 12410153
Compounds, compositions and methods
patentUS 12331107
Methods of treating pneumonia or respiratory failure associated with COVID-19 by
patentUS 11939368
QTY Fc fusion receptor proteins
patentUS 11898180
Compositions and methods for amino acid depletion therapy
patentUS 11850243
Dihydropyridine compositions and methods for treating neurological disorders
patentUS 11708406
Method of treating acute respiratory distress syndrome (ARDS) or acute lung inju
patentUS 11555060
QTY FC fusion water soluble receptor proteins
patentUS 11479576
Nucleic acid prodrugs